Preclinical efficacy and dosimetry of CD44v6-directed terbium-161 radionuclide therapy
Å. Gustafsson, Anja C. Mortensen, Veronica Rondahl, Tianqi Xu et autres
0 citationsTheranostics
Anja C. Mortensen
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
63Publications signalées
409Citations signalées
3Affiliations récentes
Institutions déclarées
Domaines associés
Cancer-related Molecular PathwaysRadiopharmaceutical Chemistry and ApplicationsThyroid Cancer Diagnosis and TreatmentMonoclonal and Polyclonal Antibodies ResearchCancer Research and Treatments
Publications récentes
Supplemental Figure 4 from Dual-Nuclide Biodistribution and Therapeutic Evaluation of a Novel Antibody-Based Radiopharmaceutical in Anaplastic Thyroid Cancer Xenografts
Anja C. Mortensen, Hanna Berglund, Preeti Jha, Adam Stenman et autres
0 citations
Supplemental Figure 3 from Dual-Nuclide Biodistribution and Therapeutic Evaluation of a Novel Antibody-Based Radiopharmaceutical in Anaplastic Thyroid Cancer Xenografts
Anja C. Mortensen, Hanna Berglund, Preeti Jha, Adam Stenman et autres
0 citations
Supplemental Figure 2 from Dual-Nuclide Biodistribution and Therapeutic Evaluation of a Novel Antibody-Based Radiopharmaceutical in Anaplastic Thyroid Cancer Xenografts
Anja C. Mortensen, Hanna Berglund, Preeti Jha, Adam Stenman et autres
0 citations
Supplemental Figure 1 from Dual-Nuclide Biodistribution and Therapeutic Evaluation of a Novel Antibody-Based Radiopharmaceutical in Anaplastic Thyroid Cancer Xenografts
Anja C. Mortensen, Hanna Berglund, Preeti Jha, Adam Stenman et autres
0 citations
Correction: Overcoming limitations of cisplatin therapy by additional treatment with the HSP90 inhibitor onalespib
Anja C. Mortensen, Tabassom Mohajershojai, Mehran Hariri, Marika Pettersson et autres
0 citationsFrontiers in Oncology
Evaluation of CD44v6-targeted radionuclide therapy on bone marrow, skin and esophageal epithelium using a novel internal dosimetry model
Jens Hemmingsson, Marika Nestor, Anja C. Mortensen, Fredrik Y. Frejd et autres
1 citationPhysics in Medicine and Biology
Preclinical Validation of [ 177 Lu]Lu-AKIR001, a CD44v6-Targeted Radiotherapeutic Entering First-in-Human Trials
Anja C. Mortensen, Tabassom Mohajershojai, Å. Gustafsson, Hanna Berglund et autres
6 citationsJournal of Nuclear Medicine
Editor’s Note: The MDM2/MDMX-p53 Antagonist PM2 Radiosensitizes Wild-Type p53 Tumors
Diana Spiegelberg, Anja C. Mortensen, Sara Lundsten, Christopher Brown et autres
0 citationsCancer Research
CD44v6 expression in non-anaplastic thyroid carcinoma: characterization of candidates for targeted therapy
Adam Stenman, Joachim N. Nilsson, Vincenzo Condello, Anja C. Mortensen et autres
1 citationThyroid Research
Author Correction: Combination therapy of tyrosine kinase inhibitor sorafenib with the HSP90 inhibitor onalespib as a novel treatment regimen for thyroid cancer
Anja C. Mortensen, Hanna Berglund, Mehran Hariri, Eleftherios Papalanis et autres
0 citationsScientific Reports
Data from Dual-Nuclide Biodistribution and Therapeutic Evaluation of a Novel Antibody-Based Radiopharmaceutical in Anaplastic Thyroid Cancer Xenografts
Anja C. Mortensen, Hanna Berglund, Preeti Jha, Adam Stenman et autres
0 citations
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.